US 12,138,475 B2
Composition of polymer gel dosimeters for radiation therapy
Khalid A. Rabaeh, Zarqa (JO); Feras M. Aldweri, Zarqa (JO); Nesreen I Udwan, Zarqa (JO); Manar K Sowan, Zarqa (JO); and Ala'a A Abu Sa'aleek, Zarqa (JO)
Assigned to Hashemite University, Zarqa (JO)
Filed by The Hashemite University, Zarqa (JO)
Filed on Jul. 29, 2021, as Appl. No. 17/388,506.
Prior Publication US 2023/0047643 A1, Feb. 16, 2023
Int. Cl. A61N 5/10 (2006.01); C08F 2/10 (2006.01); C08F 2/46 (2006.01); C08F 20/56 (2006.01); C08F 26/06 (2006.01); C08K 5/053 (2006.01); C08K 5/50 (2006.01); C08K 11/00 (2006.01)
CPC A61N 5/1029 (2013.01) [C08F 2/10 (2013.01); C08F 2/46 (2013.01); C08F 20/56 (2013.01); C08F 26/06 (2013.01); C08K 5/053 (2013.01); C08K 5/50 (2013.01); C08K 11/00 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A three-dimensional dosimeter gel, comprising;
a) a N, N′-methylene-bis-acrylamide (BIS) cross-linker wt % from 1 to 4%;
b) a Gelatin Type B wt % from 1 to 10%;
c) a Tetrakis (hydroxymethyl) phosphonium chloride (THPC) from 5-20 mM;
d) an Ethylene glycol wt % from 1 to 50%;
e) a De-ionized water as a solvent; and
f) a monomer in a specific range.